190 related articles for article (PubMed ID: 22125210)
21. Apelin-36 Modulates Blood Glucose and Body Weight Independently of Canonical APJ Receptor Signaling.
Galon-Tilleman H; Yang H; Bednarek MA; Spurlock SM; Paavola KJ; Ko B; To C; Luo J; Tian H; Jermutus L; Grimsby J; Rondinone CM; Konkar A; Kaplan DD
J Biol Chem; 2017 Feb; 292(5):1925-1933. PubMed ID: 27994053
[TBL] [Abstract][Full Text] [Related]
22. Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells.
Kleinz MJ; Skepper JN; Davenport AP
Regul Pept; 2005 Mar; 126(3):233-40. PubMed ID: 15664671
[TBL] [Abstract][Full Text] [Related]
23. The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis.
O'Carroll AM; Lolait SJ; Harris LE; Pope GR
J Endocrinol; 2013 Oct; 219(1):R13-35. PubMed ID: 23943882
[TBL] [Abstract][Full Text] [Related]
24. Cardiovascular responses to apelin in two-kidney-one-clip hypertensive rats and its receptor expression in ischemic and non-ischemic kidneys.
Soltani Hekmat A; Najafipour H; Nekooian AA; Esmaeli-Mahani S; Javanmardi K
Regul Pept; 2011 Dec; 172(1-3):62-8. PubMed ID: 21911011
[TBL] [Abstract][Full Text] [Related]
25. Blockade of the renin-angiotensin system ameliorates apelin production in 3T3-L1 adipocytes.
Hung WW; Hsieh TJ; Lin T; Chou PC; Hsiao PJ; Lin KD; Shin SJ
Cardiovasc Drugs Ther; 2011 Feb; 25(1):3-12. PubMed ID: 21161354
[TBL] [Abstract][Full Text] [Related]
26. Modulation of the apelin/APJ system in heart failure and atherosclerosis in man.
Pitkin SL; Maguire JJ; Kuc RE; Davenport AP
Br J Pharmacol; 2010 Aug; 160(7):1785-95. PubMed ID: 20649580
[TBL] [Abstract][Full Text] [Related]
27. Apelin stimulates glucose uptake but not lipolysis in human adipose tissue ex vivo.
Attané C; Daviaud D; Dray C; Dusaulcy R; Masseboeuf M; Prévot D; Carpéné C; Castan-Laurell I; Valet P
J Mol Endocrinol; 2011 Feb; 46(1):21-8. PubMed ID: 21062936
[TBL] [Abstract][Full Text] [Related]
28. The apelin receptor: physiology, pathology, cell signalling, and ligand modulation of a peptide-activated class A GPCR.
Chapman NA; Dupré DJ; Rainey JK
Biochem Cell Biol; 2014 Dec; 92(6):431-40. PubMed ID: 25275559
[TBL] [Abstract][Full Text] [Related]
29. Targeting drugs to APJ receptor: the prospect of treatment of hypertension and other cardiovascular diseases.
Cao J; Li H; Chen L
Curr Drug Targets; 2015; 16(2):148-55. PubMed ID: 25438973
[TBL] [Abstract][Full Text] [Related]
30. Apelin/APJ signaling system: a potential link between adipose tissue and endothelial angiogenic processes.
Kunduzova O; Alet N; Delesque-Touchard N; Millet L; Castan-Laurell I; Muller C; Dray C; Schaeffer P; Herault JP; Savi P; Bono F; Valet P
FASEB J; 2008 Dec; 22(12):4146-53. PubMed ID: 18708591
[TBL] [Abstract][Full Text] [Related]
31. Apelin suppresses apoptosis of human vascular smooth muscle cells via APJ/PI3-K/Akt signaling pathways.
Cui RR; Mao DA; Yi L; Wang C; Zhang XX; Xie H; Wu XP; Liao XB; Zhou H; Meng JC; Yuan LQ; Liao EY
Amino Acids; 2010 Nov; 39(5):1193-200. PubMed ID: 20495838
[TBL] [Abstract][Full Text] [Related]
32. Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells.
Kleinz MJ; Davenport AP
Regul Pept; 2004 May; 118(3):119-25. PubMed ID: 15003827
[TBL] [Abstract][Full Text] [Related]
33. Apelin/APJ System: A Novel Therapeutic Target for Myocardial Ischemia/Reperfusion Injury.
Chen Z; Wu D; Li L; Chen L
DNA Cell Biol; 2016 Dec; 35(12):766-775. PubMed ID: 27854125
[TBL] [Abstract][Full Text] [Related]
34. The apelinergic system: the role played in human physiology and pathology and potential therapeutic applications.
Ladeiras-Lopes R; Ferreira-Martins J; Leite-Moreira AF
Arq Bras Cardiol; 2008 May; 90(5):343-9. PubMed ID: 18516406
[TBL] [Abstract][Full Text] [Related]
35. Adiponectin/T-cadherin and apelin/APJ expression in human arteries and periadventitial fat: implication of local adipokine signaling in atherosclerosis?
Kostopoulos CG; Spiroglou SG; Varakis JN; Apostolakis E; Papadaki HH
Cardiovasc Pathol; 2014; 23(3):131-8. PubMed ID: 24675084
[TBL] [Abstract][Full Text] [Related]
36. Pancreatic Islet APJ Deletion Reduces Islet Density and Glucose Tolerance in Mice.
Han S; Englander EW; Gomez GA; Rastellini C; Quertermous T; Kundu RK; Greeley GH
Endocrinology; 2015 Jul; 156(7):2451-60. PubMed ID: 25965959
[TBL] [Abstract][Full Text] [Related]
37. Regulation of the endothelial apelin/APJ system by hemodynamic fluid flow.
Busch R; Strohbach A; Pennewitz M; Lorenz F; Bahls M; Busch MC; Felix SB
Cell Signal; 2015 Jul; 27(7):1286-96. PubMed ID: 25817266
[TBL] [Abstract][Full Text] [Related]
38. Maturation of blood vessels by haematopoietic stem cells and progenitor cells: involvement of apelin/APJ and angiopoietin/Tie2 interactions in vessel caliber size regulation.
Takakura N; Kidoya H
Thromb Haemost; 2009 Jun; 101(6):999-1005. PubMed ID: 19492139
[TBL] [Abstract][Full Text] [Related]
39. Biology of the apelin-APJ axis in vascular formation.
Kidoya H; Takakura N
J Biochem; 2012 Aug; 152(2):125-31. PubMed ID: 22745157
[TBL] [Abstract][Full Text] [Related]
40. Requirement of apelin-apelin receptor system for oxidative stress-linked atherosclerosis.
Hashimoto T; Kihara M; Imai N; Yoshida S; Shimoyamada H; Yasuzaki H; Ishida J; Toya Y; Kiuchi Y; Hirawa N; Tamura K; Yazawa T; Kitamura H; Fukamizu A; Umemura S
Am J Pathol; 2007 Nov; 171(5):1705-12. PubMed ID: 17884970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
